Fistula treatment: The unresolved challenge

Digestive Diseases

Volumn 28, Issue 3, 2010, Pages 556-564

  Vavricka, Stephan R ^a   Rogler, Gerhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Anti TNF agents; Ciprofloxacin; Crohn's disease; Fistula; Metronidazole

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN A; METHOTREXATE; METRONIDAZOLE; TACROLIMUS;

CONFERENCE PAPER; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE SEVERITY; HUMAN; PRIORITY JOURNAL; RECTUM FISTULA; SCORING SYSTEM;

ADRENAL CORTEX HORMONES; AMINOSALICYLIC ACIDS; CROHN DISEASE; HUMANS; INTESTINAL FISTULA; PLACEBOS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957879996     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320416     Document Type: Conference Paper

References (60)

1. McKee RF, Keenan RA: Perianal Crohn's disease: is it all bad news? Dis Colon Rectum 1996; 39: 136.
2. van Dongen LM, Lubbers EJ: Perianal fistulas in patients with Crohn's disease. Arch Surg 1986; 121:1187.
3. Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ: The natural history of fis-tulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-880.
4. Judge TA, Lichtenstein GR: Treatment of fis-tulising Crohn's disease. Gastroenterol Clin North Am 2004; 33:421-454.
5. Hellers G, Bergstrand O, Ewerth S, Holm-ström B: Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980; 21:525-527.
6. Solomon MJ: Fistulae and abscesses in symptomatic perianal Crohn's disease. Int J Colorecta l Dis 1996; 11: 222-226.
7. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB: AGA technical review on peri-anal Crohn's disease. Gastroenterology 2003; 125: 1508-1530.
8. Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-444.
9. Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, Present DH, Rutgeerts P, Schölmerich J, Stange EF, Sutherland LR: A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterolog y 2002; 122: 512-530.
10. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS: Treatment of Crohn's disease with 6-mercaptopurine: a long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981-987.
11. Irvine EJ: Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 1995; 20:27-32.
12. Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W: Antibiotics and azathioprine for the treatment of peri-anal fistulas in Crohn's disease. Aliment Pharmacol Ther 2003; 18 : 1113-1120.
13. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWood KL, Schaibl TF, van Deventer SJ: Infliximab for the treatment of fistulas with Crohn's disease. N Engl J Med 1999; 340: 1398-1405.
14. Hinojosa J, Gomollon F, Ga rcia S, Bastida G, Cabriada JL, Saro C, Ceballos D, Penate M, Gassul MA: Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial. Aliment Pharmacol Ther 2007; 25:409-418.
15. Schoepfer AM, Vavricka SR, Binek J, Felley C, Geyer M, Manz M, Rogler G, de Saussure P, Sauter B, Seibold F, Straumann A, Michet-ti P: Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey. Inflamm Bowel Dis 2010; 16: 933-938.
16. Ardizzone S, Maconi G, Colombo E, Man-zionna G, Bollani S, Bianchi Porro G: Peri-anal fistulae following inf liximab treatment: clinical and endosonographic outcome. In-flamm Bowel Dis 2004; 10:91-96.
17. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ: Infliximab maintenance therapy for fistulazing Crohn's disease. N Engl J Med 2004; 350: 876-885.
18. Bernstein LH, Frank MS, Brandt LJ, Boley SJ: Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980; 79: 357-365.
19. Brandt LJ, Bernstein LH, Boley SJ, Frank MS: Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982; 83:383-387.
20. Jakobovits J, Schuster MM: Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984; 79: 533-540.
21. Thia KT, Mahadewan U, Feagan BG, Wong CW, Cockeram A, Bitton A, Bernstein C, Sandborn WJ: Cirpofloxacin or metronida-zole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2009; 15:17-24.
22. West RL, van der Woude CJ, Hansen BE, Felt-Bersma RJ, van Tilburg AJ, Drapers JA, Kuipers J: Clinical and endosonographic effect of ciprofloxacin on the treatment of peri-anal fistulae in Crohn's disease with inflix-imab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2004; 20: 1329-1336.
23. Pearson DC, May GR, Fick GH, Sutherland LR: Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Ann Intern Med 1995; 123: 132-142.
24. Egan LJ, Sandborn WJ, Tremaine WJ: Clinical outcome following treatment of refractory inflammatory and fistulising Crohn's disease with intravenous cyclosporine. Am J Gastroenterol 1998; 93: 442-448.
25. Hanauer SB, Smith MB: Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporine. Am J Gastroenterol 1993; 88:646-649.
26. Present DH, Lichtiger S: Efficacy of cyclo-sporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994; 39: 374-380.
27. Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS: Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gas-troenterology 2003; 125:380-388.
28. González-Lama Y, Abreu L, Vera MI, Pastrana M, Tabernero S, Revilla J, Durán JG, Es-cartin P: Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease. Inflamm Bowel Dis 2005; 11:8-15.
29. Mahadevan U, Marion JF, Present DH: Fist u la re sponse to met hot rexate i n Croh n's disease: a case series. Aliment Pharmacol Ther 2003; 18 : 1003-1008.
30. Hanauer SB, Sandborn WJ, Rutgeerts P, Fe-dorak RN, Lukas M, Macintosh D, Panac-cione R, Wolf D, Pollack P: Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLAS-SIC-I trial. Gastroenterology 2006; 10:323-333.
31. Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel AF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF: Adalimumab induction therapy for Crohn disease previously treated with infliximab. Ann Intern Med 2007; 146:829-838.
32. Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schrei-ber S, Byczkowski D, Li J, Kent JD, Pollack PF: Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM Trial. Gastro-enterology 20 07; 132: 52-65.
33. Colombel JF, Schwartz DA, Sandborn WJ, Kamm MA, D'Haens G, Rutgeerts P, Enns R, Panaccione R, Schreiber S, Li J, Kent JD, Lo-max KG, Pollack PF: Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009; 5:940-948.
34. Sandborn WJ, Feagan BG, Stoinov S, Honi-ball PJ, Rutgeerts P, Mason D, Bloomfield R, Schreiber S: Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med 2007; 357: 228-238.
35. Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomson O, Hanauer SB, McColm J, Bloomfield R, Sandbron WJ: Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med 2007; 357: 239-250.
36. Fukuda Y, Takazoe M, Sugita A, Kosaka T, Kinjo F, Otani Y, Fuji H, Kohanei K, Maki-yama K, Nakamura T, et al: Oral spheric ad-sorptive carbon for the treatment of intractable anal fistulas in Crohn's disease: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2008; 103:1721-1729.
37. Pascua M, Su C, Lewis JD, Brensinger C, Lichtenstein GR: Meta-analysis: factor predicting post-operative recurrence with placebo therapy in patients with Crohn's disease. Aliment Pharmacol Ther 2008; 28:545-556.
38. Nielsen OH, Munck LK: Drug insight: ami-nosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 160-170.
39. Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M. Mortensen NJ: European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006; 55(suppl 1):i16-i35.
40. Jones JH, Lennard-Jones E: Corticosteroids and corticotropin in the treatment of Crohn's disease. Gut 1966; 7 : 181-187.
41. Sparberg M, Kirsner JB: Long-term cortico-steroid therapy for regional enteritis: an analysis off 58 courses in 54 patients. Am J Dig Dis 1966; 11:865-880.
42. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, Jesdinsky H: European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastro-enterology 1984; 86:249-266.
43. Schneider MU, Laudage G, Guggenmoos-Holzmann I, Riemann JF: Metranidazole in the treatment of Crohn's disease: results of a controlled randomized prospective study. Dtsch Med Wochenschr 1985; 110: 1724-1730.
44. Turunen U, Farkkila M, Seppala K: Long-term treatment of peri-anal or fistulous Crohn's disease with ciprofloxacin. Scand J Gastroenterol 1989; 24(suppl 48):144.
45. Wolf J: Ciprofloxacin may be useful in Crohn's disease. Gastroenterology 1990; 98:A212.
46. Casparian JM, Luchi M, Moffat RE, Hin-thorn D: Quinolones and tendon ruptures. South Med J 200 0; 93: 488-491.
47. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS: Treatment of Crohn's disease with 6-mercaptopurine: a long-term, randomized, double-blind study. N Eng J Med 1980; 302: 981-987.
48. Ng SC, Arebi N, Kamm MA: Medium-term results of oral tacrolimus for treatment of refractory inflammatory bowel disease. Inf lamm Bowel Dis 2007; 13: 129-134.
49. Sandborn WJ: A critical review of cyclo-sporine therapy in inflammatory bowel disease. Inf lamm Bowel Dis 1995; 1: 48-63.
50. Sands BE, Blank MA; Patel K, van Deventer SJ: Long-term treatment of rectovaginal fistulas in Crohn's disease: response to inflix-imab in the ACCENT II study. Clin Gastro-enterol Hepatol 2004; 2:912-920.
51. Mueller MH, Geis M, Glatzle J, Kasparek M, Meile T, Jehle EC, Kreis ME; Zittel TT: Risk of fecal diversion in complicated perianal Crohn's disease. J Gastrointest Surg 2007; 11: 529-537.
52. Loffler T, Welsch T, Muhl S, Hinz U, Schmidt J, Kienle P: Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn's disease. Int J Colorectal Dis 2009; 24:521-526.
53. Kamm M, Siew CN: Perianal fistulising Crohn's disease: a call to action. Clin Gastro-enterol Hepatol 2006; 6:7-10.
54. Yamamoto T, Allan RN, Keighley MR: Effect of fecal diversion alone on perianal Crohn's disease. World J Surg 2000; 24:1258-1262.
55. Venkatesh KS, Ramanujam P: Fibrin glue application in the treatment of recurrent ano-rectal fistulas. Dis Colon Rectum 1999; 42: 1136.
56. Sentovich SM: Fibrin glue for anal fistulas: long-term results. Dis Colon Rectum 2003; 46:498.
57. Zmora O, Neufeld D, Ziv Y, Tulchinsky H, Scott D, Khaikin M, Stepansky A, Rabau M, Koller M: Prospective, multicenter evaluation of highly concentrated fibrin glue in the treatment of complex cryptogenic perianal fistulas. Dis Colon Rectum 2005; 48:2167.
58. Loungnarath R, Dietz DW, Mutch MG, Birn-baum EH, Kodner IJ, Fleshman JW: Fibrin glue treatment of complex anal fistulas has low success rate. Dis Colon Rectum 2004; 47: 432.
59. Vitton V, Gasmi M, Barthet M, Desjeux A, Orsoni P, Grimaud JC: Long-term healing of Crohn's anal fistulas with fibrin glue injection. Aliment Pharmacol Ther 2005; 21:1453.
60. De la Portilla F, Rada R, León E, Cisneros N, Maldonado VH, Espinosa E: Evaluation of the use of BioGlue in the treatment of high anal fistulas: preliminary results of a pilot study. Dis Colon Rectum 2007; 50:218.